Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 115

1.

The impact of a remote monitoring system of healthcare resource consumption in patients on automated peritoneal dialysis (APD): A simulation study
.

Uchiyama K, Washida N, Yube N, Kasai T, Shinozuka K, Morimoto K, Hishikawa A, Inoue H, Urai H, Hagiwara A, Fujii K, Wakino S, Deenitchina S, Itoh H.

Clin Nephrol. 2018 Nov;90(5):334-340. doi: 10.5414/CN109471.

PMID:
30106369
2.

Adhesive intestinal obstruction increases the risk of intestinal perforation in peritoneal dialysis patients: a case report.

Fujii K, Washida N, Arai E, Tsuruta M, Wakino S, Itoh H.

BMC Nephrol. 2018 Jun 28;19(1):153. doi: 10.1186/s12882-018-0954-x.

3.

NNMT activation can contribute to the development of fatty liver disease by modulating the NAD + metabolism.

Komatsu M, Kanda T, Urai H, Kurokochi A, Kitahama R, Shigaki S, Ono T, Yukioka H, Hasegawa K, Tokuyama H, Kawabe H, Wakino S, Itoh H.

Sci Rep. 2018 Jun 5;8(1):8637. doi: 10.1038/s41598-018-26882-8.

4.

High Basolateral Glucose Increases Sodium-Glucose Cotransporter 2 and Reduces Sirtuin-1 in Renal Tubules through Glucose Transporter-2 Detection.

Umino H, Hasegawa K, Minakuchi H, Muraoka H, Kawaguchi T, Kanda T, Tokuyama H, Wakino S, Itoh H.

Sci Rep. 2018 May 1;8(1):6791. doi: 10.1038/s41598-018-25054-y.

5.

Oral adsorbent AST-120 ameliorates gut environment and protects against the progression of renal impairment in CKD rats.

Yoshifuji A, Wakino S, Irie J, Matsui A, Hasegawa K, Tokuyama H, Hayashi K, Itoh H.

Clin Exp Nephrol. 2018 Oct;22(5):1069-1078. doi: 10.1007/s10157-018-1577-z. Epub 2018 Apr 19.

6.

Penile calciphylaxis in a patient on combined peritoneal dialysis and hemodialysis.

Kasai T, Washida N, Muraoka H, Fujii K, Uchiyama K, Shinozuka K, Morimoto K, Tokuyama H, Wakino S, Itoh H.

CEN Case Rep. 2018 Nov;7(2):204-207. doi: 10.1007/s13730-018-0327-0. Epub 2018 Mar 28.

7.

Non-Tuberculous Mycobacterial Infections Related to Peritoneal Dialysis.

Inoue H, Washida N, Morimoto K, Shinozuka K, Kasai T, Uchiyama K, Tokuyama H, Wakino S, Itoh H.

Perit Dial Int. 2018 Mar-Apr;38(2):147-149. doi: 10.3747/pdi.2017.00172.

PMID:
29563276
8.

Aldosterone and Insulin Resistance: Vicious Combination in Patients on Maintenance Hemodialysis.

Wakino S, Minakuchi H, Miya K, Takamatsu N, Tada H, Tani E, Inamoto H, Minakuchi J, Kawashima S, Itoh H.

Ther Apher Dial. 2018 Apr;22(2):142-151. doi: 10.1111/1744-9987.12632. Epub 2017 Dec 22.

PMID:
29271574
9.

Ghrelin treatment improves physical decline in sarcopenia model mice through muscular enhancement and mitochondrial activation.

Tamaki M, Miyashita K, Hagiwara A, Wakino S, Inoue H, Fujii K, Fujii C, Endo S, Uto A, Mitsuishi M, Sato M, Doi T, Itoh H.

Endocr J. 2017;64(Suppl.):S47-S51. doi: 10.1507/endocrj.64.S47.

10.

Temporal trends in renal function and birthweight in Japanese adolescent males (1998-2015).

Kanda T, Takeda A, Hirose H, Abe T, Urai H, Inokuchi M, Wakino S, Tokumura M, Itoh H, Kawabe H.

Nephrol Dial Transplant. 2018 Feb 1;33(2):304-310. doi: 10.1093/ndt/gfw428.

11.

Generation of kidney tubular organoids from human pluripotent stem cells.

Yamaguchi S, Morizane R, Homma K, Monkawa T, Suzuki S, Fujii S, Koda M, Hiratsuka K, Yamashita M, Yoshida T, Wakino S, Hayashi K, Sasaki J, Hori S, Itoh H.

Sci Rep. 2016 Dec 16;6:38353. doi: 10.1038/srep38353.

12.

Obesity-induced kidney injury is attenuated by amelioration of aberrant PHD2 activation in proximal tubules.

Futatsugi K, Tokuyama H, Shibata S, Naitoh M, Kanda T, Minakuchi H, Yamaguchi S, Hayashi K, Minamishima YA, Yanagita M, Wakino S, Itoh H.

Sci Rep. 2016 Nov 9;6:36533. doi: 10.1038/srep36533.

13.

2016 Guidelines for the management of thyroid storm from The Japan Thyroid Association and Japan Endocrine Society (First edition).

Satoh T, Isozaki O, Suzuki A, Wakino S, Iburi T, Tsuboi K, Kanamoto N, Otani H, Furukawa Y, Teramukai S, Akamizu T.

Endocr J. 2016 Dec 30;63(12):1025-1064. doi: 10.1507/endocrj.EJ16-0336. Epub 2016 Oct 15.

14.

[The clinical characteristics of hypertension in chronic kidney disease.]

Wakino S.

Nihon Naika Gakkai Zasshi. 2016 May;105(5):793-801. Japanese. No abstract available.

PMID:
29182830
15.

Communication from Tubular Epithelial Cells to Podocytes through Sirt1 and Nicotinic Acid Metabolism.

Hasegawa K, Wakino S, Sakamaki Y, Muraoka H, Umino H, Minakuchi H, Yoshifuji A, Naitoh M, Shinozuka K, Futatsugi K, Urai H, Kanda T, Tokuyama H, Hayashi K, Itoh H.

Curr Hypertens Rev. 2016;12(2):95-104. Review.

PMID:
26931474
16.

Comparison of the effects of low-dose rosuvastatin on plasma levels of cholesterol and oxidized low-density lipoprotein in 3 ultracentrifugally separated low-density lipoprotein subfractions.

Homma K, Homma Y, Ozawa H, Shiina Y, Shibata T, Yoshida T, Hasegawa K, Kanda T, Tokuyama H, Wakino S, Hayashi K, Itoh H, Hori S.

J Clin Lipidol. 2015 Nov-Dec;9(6):751-757. doi: 10.1016/j.jacl.2015.07.013. Epub 2015 Aug 7.

PMID:
26687695
17.

A case of severe osteomalacia caused by Tubulointerstitial nephritis with Fanconi syndrome in asymptomotic primary biliary cirrhosis.

Yamaguchi S, Maruyama T, Wakino S, Tokuyama H, Hashiguchi A, Tada S, Homma K, Monkawa T, Thomas J, Miyashita K, Kurihara I, Yoshida T, Konishi K, Hayashi K, Hayashi M, Itoh H.

BMC Nephrol. 2015 Nov 11;16:187. doi: 10.1186/s12882-015-0184-4.

18.

The role of adipose tissue asymmetric dimethylarginine/dimethylarginine dimethylaminohydrolase pathway in adipose tissue phenotype and metabolic abnormalities in subtotally nephrectomized rats.

Minakuchi H, Wakino S, Hosoya K, Sueyasu K, Hasegawa K, Shinozuka K, Yoshifuji A, Futatsugi K, Komatsu M, Kanda T, Tokuyama H, Hayashi K, Itoh H.

Nephrol Dial Transplant. 2016 Mar;31(3):413-23. doi: 10.1093/ndt/gfv367. Epub 2015 Oct 28.

PMID:
26516203
19.

Gut Lactobacillus protects against the progression of renal damage by modulating the gut environment in rats.

Yoshifuji A, Wakino S, Irie J, Tajima T, Hasegawa K, Kanda T, Tokuyama H, Hayashi K, Itoh H.

Nephrol Dial Transplant. 2016 Mar;31(3):401-12. doi: 10.1093/ndt/gfv353. Epub 2015 Oct 20.

PMID:
26487672
20.

Treatment and management of thyroid storm: analysis of the nationwide surveys: The taskforce committee of the Japan Thyroid Association and Japan Endocrine Society for the establishment of diagnostic criteria and nationwide surveys for thyroid storm.

Isozaki O, Satoh T, Wakino S, Suzuki A, Iburi T, Tsuboi K, Kanamoto N, Otani H, Furukawa Y, Teramukai S, Akamizu T.

Clin Endocrinol (Oxf). 2016 Jun;84(6):912-8. doi: 10.1111/cen.12949. Epub 2015 Oct 28.

PMID:
26387649
21.

Improvement of Physical Decline Through Combined Effects of Muscle Enhancement and Mitochondrial Activation by a Gastric Hormone Ghrelin in Male 5/6Nx CKD Model Mice.

Tamaki M, Hagiwara A, Miyashita K, Wakino S, Inoue H, Fujii K, Fujii C, Sato M, Mitsuishi M, Muraki A, Hayashi K, Doi T, Itoh H.

Endocrinology. 2015 Oct;156(10):3638-48. doi: 10.1210/en.2015-1353. Epub 2015 Aug 4.

PMID:
26241123
22.

Renin-angiotensin blockade resets podocyte epigenome through Kruppel-like Factor 4 and attenuates proteinuria.

Hayashi K, Sasamura H, Nakamura M, Sakamaki Y, Azegami T, Oguchi H, Tokuyama H, Wakino S, Hayashi K, Itoh H.

Kidney Int. 2015 Oct;88(4):745-53. doi: 10.1038/ki.2015.178. Epub 2015 Jun 24.

PMID:
26108068
23.

Sirtuin and metabolic kidney disease.

Wakino S, Hasegawa K, Itoh H.

Kidney Int. 2015 Oct;88(4):691-8. doi: 10.1038/ki.2015.157. Epub 2015 Jun 17. Review.

24.

Impact of Switching From Darbepoetin Alfa to Epoetin Beta Pegol on Iron Utilization and Blood Pressure in Peritoneal Dialysis Patients.

Washida N, Inoue S, Kasai T, Shinozuka K, Hosoya K, Morimoto K, Wakino S, Hayashi K, Itoh H.

Ther Apher Dial. 2015 Oct;19(5):450-6. doi: 10.1111/1744-9987.12306. Epub 2015 May 5.

PMID:
25944557
25.

Changes in ultracentrifugally separated plasma lipoprotein subfractions in patients with polygenic hypercholesterolemia, familial combined hyperlipoproteinemia, and familial hypercholesterolemia after treatment with atorvastatin.

Homma K, Homma Y, Yoshida T, Ozawa H, Shiina Y, Wakino S, Hayashi K, Itoh H, Hori S.

J Clin Lipidol. 2015 Mar-Apr;9(2):210-6. doi: 10.1016/j.jacl.2014.12.007. Epub 2014 Dec 16.

PMID:
25911077
26.

Improvement in karyomegalic interstitial nephritis three years after ifosfamide and cisplatin therapy by corticosteroid.

Matsuura T, Wakino S, Yoshifuji A, Nakamura T, Tokuyama H, Hashiguchi A, Konishi K, Iwasa T, Shoji M, Hosono A, Ohashi K, Chuman H, Itoh H.

CEN Case Rep. 2014 Nov;3(2):226-231. doi: 10.1007/s13730-014-0124-3. Epub 2014 Jun 4.

27.

Insulin resistance in chronic kidney disease is ameliorated by spironolactone in rats and humans.

Hosoya K, Minakuchi H, Wakino S, Fujimura K, Hasegawa K, Komatsu M, Yoshifuji A, Futatsugi K, Shinozuka K, Washida N, Kanda T, Tokuyama H, Hayashi K, Itoh H.

Kidney Int. 2015 Apr;87(4):749-60. doi: 10.1038/ki.2014.348. Epub 2014 Oct 22.

PMID:
25337775
28.

A case of thyroid storm with a markedly elevated level of circulating soluble interleukin-2 receptor complicated by multiple organ failure and disseminated intravascular coagulation syndrome.

Shimoda Y, Satoh T, Takahashi H, Katano-Toki A, Ozawa A, Tomaru T, Horiguchi N, Kaira K, Nishioka M, Shibusawa N, Hashimoto K, Wakino S, Mori M, Yamada M.

Endocr J. 2014;61(7):691-6. Epub 2014 May 20.

29.

Ghrelin protects against renal damages induced by angiotensin-II via an antioxidative stress mechanism in mice.

Fujimura K, Wakino S, Minakuchi H, Hasegawa K, Hosoya K, Komatsu M, Kaneko Y, Shinozuka K, Washida N, Kanda T, Tokuyama H, Hayashi K, Itoh H.

PLoS One. 2014 Apr 18;9(4):e94373. doi: 10.1371/journal.pone.0094373. eCollection 2014.

30.

Rho-kinase contributes to pressure-induced constriction of renal microvessels.

Homma K, Hayashi K, Wakino S, Tokuyama H, Kanda T, Tatematsu S, Hasegawa K, Fujishima S, Hori S, Saruta T, Itoh H.

Keio J Med. 2014;63(1):1-12. Epub 2014 Jan 16.

31.

Chronic kidney disease reduces muscle mitochondria and exercise endurance and its exacerbation by dietary protein through inactivation of pyruvate dehydrogenase.

Tamaki M, Miyashita K, Wakino S, Mitsuishi M, Hayashi K, Itoh H.

Kidney Int. 2014 Jun;85(6):1330-9. doi: 10.1038/ki.2013.473. Epub 2013 Nov 27.

32.

Serum creatinine and albumin decline predict the contraction of nosocomial aspiration pneumonia in patients undergoing hemodialysis.

Minakuchi H, Wakino S, Hayashi K, Inamoto H, Itoh H.

Ther Apher Dial. 2014 Aug;18(4):326-33. doi: 10.1111/1744-9987.12143. Epub 2013 Nov 12.

PMID:
24215304
33.

Renal tubular Sirt1 attenuates diabetic albuminuria by epigenetically suppressing Claudin-1 overexpression in podocytes.

Hasegawa K, Wakino S, Simic P, Sakamaki Y, Minakuchi H, Fujimura K, Hosoya K, Komatsu M, Kaneko Y, Kanda T, Kubota E, Tokuyama H, Hayashi K, Guarente L, Itoh H.

Nat Med. 2013 Nov;19(11):1496-504. doi: 10.1038/nm.3363. Epub 2013 Oct 20.

34.

Skew of plasma low- and high-density lipoprotein distributions to less dense subfractions in normotriglyceridemic chronic kidney disease patients on maintenance hemodialysis treatment.

Homma K, Homma Y, Shiina Y, Wakino S, Suzuki M, Fujishima S, Hayashi K, Hori S, Itoh H.

Nephron Clin Pract. 2013;123(1-2):41-5. doi: 10.1159/000351506. Epub 2013 Jun 6.

PMID:
23752220
35.

Severe systemic calciphylaxis with culture-negative endocarditis.

Azegami T, Wakino S, Hayashi M, Itoh H.

Clin Kidney J. 2013 Jun;6(3):342-3. doi: 10.1093/ckj/sft019. Epub 2013 Apr 14. No abstract available.

36.

The hydrolase DDAH2 enhances pancreatic insulin secretion by transcriptional regulation of secretagogin through a Sirt1-dependent mechanism in mice.

Hasegawa K, Wakino S, Kimoto M, Minakuchi H, Fujimura K, Hosoya K, Komatsu M, Kaneko Y, Kanda T, Tokuyama H, Hayashi K, Itoh H.

FASEB J. 2013 Jun;27(6):2301-15. doi: 10.1096/fj.12-226092. Epub 2013 Feb 21.

PMID:
23430976
37.

A large coronary aneurysm and its probable precursor lesions in a patient with autosomal dominant polycystic kidney disease: an implication for the process of aneurysmogenesis.

Ohara K, Kimura T, Karasawa T, Tokuyama H, Wakino S, Hayashi K, Itoh H, Okada Y.

Pathol Int. 2012 Nov;62(11):758-62. doi: 10.1111/pin.12007.

PMID:
23121608
38.

[Chronic kidney disease (CKD)--recent progress. Topics: VI. Chronic kidney disease (CKD) and associated disorders; 6. CKD associated with obesity and metabolic syndrome].

Wakino S, Otoh H.

Nihon Naika Gakkai Zasshi. 2012 May 10;101(5):1310-7. Review. Japanese. No abstract available.

PMID:
22693851
39.

Diagnostic criteria, clinical features, and incidence of thyroid storm based on nationwide surveys.

Akamizu T, Satoh T, Isozaki O, Suzuki A, Wakino S, Iburi T, Tsuboi K, Monden T, Kouki T, Otani H, Teramukai S, Uehara R, Nakamura Y, Nagai M, Mori M; Japan Thyroid Association.

Thyroid. 2012 Jul;22(7):661-79. doi: 10.1089/thy.2011.0334. Epub 2012 Jun 12. Erratum in: Thyroid. 2012 Sep;22(9):979.

40.

MPO-ANCA associated crescentic glomerulonephritis with numerous immune complexes: case report.

Morizane R, Konishi K, Hashiguchi A, Tokuyama H, Wakino S, Kawabe H, Hayashi M, Hayashi K, Itoh H.

BMC Nephrol. 2012 Jun 1;13:32. doi: 10.1186/1471-2369-13-32.

41.

Triglyceride-rich lipoproteins in chronic kidney disease patients undergoing maintenance haemodialysis treatment.

Homma K, Homma Y, Yamaguchi S, Shiina Y, Wakino S, Hayashi K, Hori S, Itoh H.

Int J Clin Pract. 2012 Apr;66(4):394-8. doi: 10.1111/j.1742-1241.2011.02862.x.

PMID:
22420498
42.

Role of mineralocorticoid receptor/Rho/Rho-kinase pathway in obesity-related renal injury.

Tokuyama H, Wakino S, Hara Y, Washida N, Fujimura K, Hosoya K, Yoshioka K, Hasegawa K, Minakuchi H, Homma K, Hayashi K, Itoh H.

Int J Obes (Lond). 2012 Aug;36(8):1062-71. doi: 10.1038/ijo.2011.232. Epub 2011 Dec 20.

43.

[Mitochondrial dysfunction in metabolic syndrome].

Wakino S, Itoh H.

Nihon Rinsho. 2011 Jan;69 Suppl 1:26-31. Review. Japanese. No abstract available.

PMID:
21766569
44.

Rho-kinase inhibition ameliorates peritoneal fibrosis and angiogenesis in a rat model of peritoneal sclerosis.

Washida N, Wakino S, Tonozuka Y, Homma K, Tokuyama H, Hara Y, Hasegawa K, Minakuchi H, Fujimura K, Hosoya K, Hayashi K, Itoh H.

Nephrol Dial Transplant. 2011 Sep;26(9):2770-9. doi: 10.1093/ndt/gfr012. Epub 2011 Mar 4.

PMID:
21378147
45.

A case of membranous nephropathy with primary biliary cirrhosis and cyclosporine-induced remission.

Sakamaki Y, Hayashi M, Wakino S, Fukuda S, Konishi K, Hashiguchi A, Hayashi K, Itoh H.

Intern Med. 2011;50(3):233-8. Epub 2011 Feb 1.

46.

Rho and Rho-kinase activity in adipocytes contributes to a vicious cycle in obesity that may involve mechanical stretch.

Hara Y, Wakino S, Tanabe Y, Saito M, Tokuyama H, Washida N, Tatematsu S, Yoshioka K, Homma K, Hasegawa K, Minakuchi H, Fujimura K, Hosoya K, Hayashi K, Nakayama K, Itoh H.

Sci Signal. 2011 Jan 25;4(157):ra3. doi: 10.1126/scisignal.2001227.

47.

T-type Ca channel blockade as a determinant of kidney protection.

Hayashi K, Homma K, Wakino S, Tokuyama H, Sugano N, Saruta T, Itoh H.

Keio J Med. 2010;59(3):84-95. Review.

48.

Acute interstitial nephritis associated with ulcerative colitis.

Tokuyama H, Wakino S, Konishi K, Hashiguchi A, Hayashi K, Itoh H.

Clin Exp Nephrol. 2010 Oct;14(5):483-6. doi: 10.1007/s10157-010-0294-z. Epub 2010 May 25.

PMID:
20499124
49.

Parachute mitral valve incidentally diagnosed in an adult patient with hypertension.

Motoda H, Murata M, Iwanaga S, Matsushita K, Nakamizo H, Wakino S, Murata M, Ogawa S.

J Echocardiogr. 2010 Mar;8(1):28-9. doi: 10.1007/s12574-009-0024-2. Epub 2009 Nov 14.

PMID:
27278542
50.

Supplemental Content

Loading ...
Support Center